-
China's biological aviation coal has achieved the first large-scale industrial trial production
Time of Update: 2023-02-12
The reporter learned from the Information Office of Sinopec a few days ago that China's first set of bio-jet coal industrial devices produced bio-jet coal for the first time in Sinopec Zhenhai Refining and Chemical.
-
Ruichuang Biologics was approved for IND for the new indication of universal DNT cell therapy
Time of Update: 2023-02-03
January 8, 2023 / eMedClub News / -- January 6, 2023, Guangdong Ruishun Biotech Co. , Ltd. (hereinafter referred to as "Wyze Biotech CO. , Ltd. "), a biopharmaceutical company focusing on the R&D and
-
Use the sword of biological network big data to solve the mystery of corn genetics
Time of Update: 2023-02-03
Inheritance and innovation kicked off the era of maize multi-dimensional network map On December 30, 2022, the journal Nature and Genetics published the collaborative research paper "A multi-omics in
-
The net outflow of funds of 5 pharmaceutical and biological stocks exceeded 100 million yuan
Time of Update: 2023-02-03
According to the statistics of capital flow data, among the stocks with a net outflow of funds from the pharmaceutical and biological industry on December 29, there were 5 stocks with a net outflow o
-
Nature sub-issue: Breakthrough! Sui Jianhua's team at Beijing Institute of Biological Sciences has
Time of Update: 2023-02-03
The results illustrate that the anti-tumor function of S1-F4 is dependent on macrophages and DCs. Further analysis revealed that CD8+ T cells also play an important role in the antitumor effect of S1-F4, and that S1-F4 therapy can induce the generation of antigen-specific long-term immune memory.
-
The current inflection point of pharmaceutical stocks has arrived! Many pharmaceutical companies such as Zai Lab and Junshi Biologics rose sharply
Time of Update: 2023-02-03
On the news, new data from the Stock Exchange shows that on December 22, JPMorgan Chase & Co. increased its holdings in Zai Lab again, buying about 13 million shares on the same day, and the proportion of good positions rose from 8.
-
Measurement of 16-year biological aging and cognitive decline based on DNA methylation
Time of Update: 2023-02-03
”DNA methylation-based measures of biological aging and cognitive decline over 16-years: preliminary longitudinal findings in midlife Image: Figure 3.
”DNA methylation-based measures of biological aging and cognitive decline over 16-years: preliminary longitudinal findings in midlife Image: Figure 3.
-
The development prospects of the domestic pharmaceutical and biological innovation track are promising, and the investment and financing are active!
Time of Update: 2023-02-03
js?cdnversion='+~(-new Date()/36e5)];Looking back on 2022, investment and financing in the field of medicine and biology can be said to be very active.
js?cdnversion='+~(-new Date()/36e5)];Looking back on 2022, investment and financing in the field of medicine and biology can be said to be very active.
-
Alphyn Biologics reports positive results from the first cohort of a Phase 2a trial for the treatment of mild to moderate atopic dermatitis
Time of Update: 2023-02-03
js?cdnversion='+~(-new Date()/36e5)];Alphyn Biologics, a clinical-stage dermatology company that develops the first multi-target therapeutic, announced January 5 positive results in its Phase 2a clinical trial for the treatment of mild to moderate atopic dermatitis (AD) topical AB-101a.
-
The pharmaceutical and biological industries have frequently reduced their holdings
Time of Update: 2023-02-03
On January 4, Jichuan Pharmaceutical was reduced by 931,500 shares by Shanghai Stock Connect, and the new holdings were 39,609,300 shares, accounting for 4.
On January 4, Jichuan Pharmaceutical was reduced by 931,500 shares by Shanghai Stock Connect, and the new holdings were 39,609,300 shares, accounting for 4.
-
Another biological drug "upstart" went to Hong Kong to ring the bell! What are the highlights of Boan Biotech, which holds two commercial products?
Time of Update: 2023-02-03
Since the second half of this year, the Hong Kong IPO market has gradually shown signs of recovery. On December 30, Shandong Boan Biotechnology Co. , Ltd. (hereinafter referred to as "Boan Biotechnolo
-
Corteva launches Lumialza, Brazil's first biological nematicide for seed treatment
Time of Update: 2023-02-02
According to Cordeeva, Lumialzam products focus on soybeans and corn, bionematicides that control major nematodes and provide "protection of production potential," helping to "promote soil health and restore soil in a sustainable way.
-
LDC will partner with Koppert to sell biologics in Brazil
Time of Update: 2023-02-02
World Agrochemical Network Chinese reported: Trading companies Louis Dreyfus (LDC) and Koppert Biosystems (Koppert) have recently formed a partnership to jointly sell and promote the use of biological products in Brazil.
-
Intestinal selective biologics help achieve severe treatment-naïve UC and moderately recurrent UC!
Time of Update: 2023-02-02
For medical professionals onlyWhen conventional treatment of UC is ineffective, prompt application of vedelizumab can show efficacy. Ulcerative colitis (UC) is a chronic, nonspecific inflammatory diso
-
Solvay's Zhangjiagang biological recycling production line is certified
Time of Update: 2023-02-02
On December 30, 2022, Solvay announced that its biocyclic Fentamine DMAPA1UP production line at its Zhangjiagang plant has been awarded International Sustainability and Carbon Certification (ISCC).
On December 30, 2022, Solvay announced that its biocyclic Fentamine DMAPA1UP production line at its Zhangjiagang plant has been awarded International Sustainability and Carbon Certification (ISCC).